US Broker Ratings

Alvotech (ALVO) Stock Analysis: Exploring a 425% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) is making waves in the healthcare sector, primarily through its innovative approach to biosimilar medicines. Operating from Luxembourg, Alvotech is carving a niche within the specialty and..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 57% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology sector, pioneering advancements in gene editing with its cutting-edge CRISPR/Cas9 technology. Based in Zug, Switzerland, this innovative company..

Guardian Pharmacy Services, Inc. (GRDN): Analyst Ratings Suggest a Promising 6% Upside for Healthcare Investors

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) emerges as a compelling opportunity for investors looking to tap into the healthcare sector, especially within the niche of medical care facilities. With a..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 5.41% Upside in a Dynamic Healthcare Sector

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector specializing in generic and specialty drug manufacturing, is drawing attention from investors with a notable potential upside of..

HUTCHMED (China) Limited (HCM) Stock Analysis: Unpacking a 39% Potential Upside in the Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM) is a prominent player in the healthcare sector, specializing in the discovery and commercialization of targeted therapeutics and immunotherapies for cancer and immunological diseases. With..

Omnicell, Inc. (OMCL) Investor Outlook: Examining a 45% Potential Upside Amid Healthcare Innovation

Omnicell, Inc. (OMCL) stands as a dynamic player in the healthcare sector, specifically in health information services. With a market capitalization of $1.82 billion, Omnicell is strategically positioned in the..

Zai Lab Limited (ZLAB): A Biotech Contender with 120% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, stands at a compelling crossroads for investors seeking growth opportunities in the healthcare industry. Headquartered in Pudong, China,..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Play with 34.71% Upside Potential

NewAmsterdam Pharma Company N.V. (NAMS), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial market potential. Headquartered in Naarden, the Netherlands, NewAmsterdam..

Organon & Co. (OGN) Stock Analysis: Navigating a Potential Upside Amidst a Challenging Landscape

Organon & Co. (NYSE: OGN) presents a unique case for investors navigating the intricate landscape of the healthcare sector. With a market capitalization of $2.06 billion, this New Jersey-based pharmaceutical..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech Play with 31.34% Potential Upside

Investors eyeing the biotechnology sector may find Liquidia Corporation (NASDAQ: LQDA) an intriguing proposition. With its current market cap standing at $2.85 billion, Liquidia is making waves in the healthcare..

Catalyst Pharmaceuticals, Inc. (CPRX): Strong Buy Ratings and 43% Potential Upside Propel Investor Interest

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is drawing significant attention from investors, bolstered by a robust set of buy ratings and an impressive potential upside of 43.39%. This Coral Gables, Florida-based..

Celldex Therapeutics (CLDX) Investor Outlook: Exploring the 119% Potential Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector with its cutting-edge approach to treating severe inflammatory, allergic, and autoimmune diseases. Despite the challenging financial metrics typical..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Promising Biotech with 17.7% Upside Potential

For investors with a keen eye on the biotechnology landscape, Protagonist Therapeutics, Inc. (NASDAQ: PTGX) presents a compelling opportunity. With its roots in developing innovative peptide therapeutics, this Newark, California-based..

Enovis Corporation (ENOV) Stock Analysis: A Promising 101% Upside in the Healthcare Sector

Enovis Corporation (ENOV), a key player in the healthcare sector, is captivating investor attention with its potential upside of over 101%. Operating within the medical devices industry, Enovis is strategically..

Concentra Group Holdings Parent (CON) Stock Analysis: A 22% Upside Potential with Robust Growth Metrics

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a significant player in the U.S. healthcare sector, particularly in the medical care facilities industry, presents a compelling opportunity for investors seeking growth..

PROCEPT BioRobotics (PRCT) Stock Analysis: Unpacking the 85% Upside Potential

For investors keen on the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) offers a compelling opportunity. Specializing in transformative medical devices, this surgical robotics company is focused on revolutionizing urology..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a Potential 100% Upside

For investors seeking opportunities in the healthcare sector, GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing case with its significant potential upside. The company, with a market capitalization of $788.71..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 376% Upside in Biotechnology

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology sector, is capturing investor attention with its pioneering approach to cancer treatment through immunotherapy. With a market capitalization of..

CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a Potential 36.95% Upside in the Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON), a dynamic player in the healthcare sector, is capturing investor attention with its promising pipeline of bladder cancer therapies and an impressive potential upside of..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 31.39% Potential Upside for Savvy Investors

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, has piqued investor interest with its diverse portfolio and substantial growth potential. Headquartered in Laval, Canada, Bausch..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds